Document:

Letter Agreement

 Exhibit 10.1 
 [COMPANY LETTERHEAD] 
 March 21, 2006 
 Gregory M. Ayers 
 7657 Via Vivaldi 
 San Diego, CA 92127 
 Re: Employment Agreement 
 Dear Greg: 
 As you know, you and CryoCor, Inc. (“CryoCor”) entered into a Fourth Amended And Restated Executive Employment Agreement on
November 30, 2002, which was amended June 30, 2004 (collectively the “Agreement”). The purpose of this letter is to set forth an additional amendment to the Agreement, the terms of which are set forth below. Except as
specifically amended by this letter, the terms of the Agreement shall remain in full force and effect. You will continue to serve as a Class III Director of CryoCor until your resignation, non-election or removal by CryoCor’s stockholders from
that position, regardless of whether you also continue to serve as a CryoCor employee. You and CryoCor acknowledge and agree that, under current Delaware law and CryoCor’s current certificate of incorporation, CryoCor’s Directors may only
be removed as such by CryoCor’s stockholders for cause. 
 1. Section 2.1 is amended and restated as follows: “Subject to the provisions
hereof, Ayers is a full-time at-will employee of CryoCor and shall report to Dr. Edward F. Brennan in Dr. Brennan’s capacity as an officer of CryoCor and/or representative of CryoCor’s Board of Directors and shall have
duties and responsibilities in connection with the management of CryoCor’s medical affairs or clinical trials assigned by Dr. Brennan. CryoCor reserves the right to modify Ayers’ position or duties at any time in its sole and absolute
discretion, provided that Ayers continues to report to Dr. Brennan and Ayers’ duties continue to involve the management of CryoCor’s medical affairs or clinical trials.” 
 2. Section 2.2 is amended and restated as follows: “During Ayers’ employment by CryoCor, Ayers shall devote Ayers’ full business energies, interest,
abilities and productive time, during normal business hours, to the proper and efficient performance of Ayers’ duties under this Agreement. Notwithstanding the foregoing, Ayers may serve on the board of directors of no more than two other
companies in addition to serving on CryoCor’s Board of Directors.” 
 3. Section 3 of the Agreement is amended and restated as follows:
“Unless extended by mutual agreement of Ayers and CryoCor in a writing signed by Ayers and, on behalf of CryoCor, by an officer, director or employee authorized to do so by CryoCor’s Board of Directors, this Agreement shall expire on
August 31, 2006 and Ayers’ employment with CryoCor will terminate at that time. Nothing in this paragraph shall alter the at-will status of Ayers’ employment.” 
 4. Section 4.2(a) of the Agreement is amended and restated as follows: “(a) Ayers has previously been granted (i) incentive stock options to purchase (A) 7,526 shares of CryoCor 

 
common stock (“Common Stock”) under CryoCor, Inc.’s 2000 Stock Option Plan (the “Plan”) at an exercise price equal to $13.02 per
share, subject to the terms of the option agreement related thereto (the “First Option”), (B) 12,388 shares of Common Stock under the Plan at an exercise price equal to $8.37 per share, subject to the terms of the option agreement
related thereto (the “Second Option”), (C) 48,054 shares of Common Stock under the Plan at an exercise price equal to $0.62 per share, subject to the terms of an option agreement related thereto (the “Third Option”) and
(D) 161,290 shares of Common Stock under the Plan at an exercise price equal to $0.62 per share, subject to the terms of an option agreement related thereto (the “Fourth Option”) and (ii) a nonqualified stock option to purchase
123,039 shares of Common Stock under the Plan at an exercise price equal to $0.62 per share, subject to the terms of an option agreement related thereto (the “Fifth Option” and together with the First Option, Second Option, Third Option
and Fourth Option, the “Options”). The First Option and Second Option have been adjusted to reflect the 1 for 3 reverse stock split of CryoCor’s capital stock effected on September 26, 2002 and all of the Options have been
adjusted to reflect the 1 for 31 reverse stock split of CryoCor’s capital stock effected on July 6, 2005.” 
 5. Sections 5.5, 5.6 and 6.2 of
the Agreement and Exhibit B of the Agreement, and references thereto in the Agreement, are hereby deleted in their entirety. 
 6. The first paragraph of
Section 7.2 of the Agreement is amended and restated as follows: “CryoCor may terminate Ayers’ employment without Cause at any time with written notice. In the event of such termination, Ayers will receive the “Separation
Package” described in subsection 7.2(a) below, provided that Ayers complies with the conditions set forth in 7.2(b) below. All other CryoCor obligations to Ayers pursuant to this Agreement will become automatically terminated and completely
extinguished as of such termination of employment; provided Ayers shall have rights with respect to the Options as provided in the respective option agreements related thereto, as modified pursuant to the terms of this Agreement.” 

7. Section 7.2(a) is amended and restated as follows: “The Separation Package shall consist of $450,000, provided that the foregoing payment shall be
subject to standard deductions and withholdings and payable in equal installments over twelve months in accordance with CryoCor’s regular payroll cycle. Notwithstanding the foregoing, but subject to the immediately succeeding sentence, the
timing for payment of all or any portion of the Separation Package, or any other payment required under this Agreement, may be delayed at CryoCor’s discretion to the minimum extent necessary (but not to exceed six months) (any such delay, an
“Applicable Delay”) so that such payment or payments are not subject to Section 409A(a)(1) of the Internal Revenue Code of 1986, as amended, by reason of a failure to comply with Section 409A(a)(2)(B)(i). In the event of any
Applicable Delay, Ayers shall receive, at the time he first receives all or any portion of any payment or payments subject to an Applicable Delay (the “Delayed Payment Receipt Time”), an amount equal to the applicable payment or payments
due at the Delayed Payment Receipt Time plus all other applicable payments he would have otherwise already received prior to the Delayed Payment Receipt Time but for the Applicable Delay, and thereafter shall receive any remaining applicable payment
or payments that are part of the payment or payments subject to the Applicable Delay but due after the Delayed Payment Receipt Time in equal installments over the remainder of the applicable twelve-month period in accordance with CryoCor’s
regular payroll cycle, subject, in each case, to standard deductions 

 
and withholdings. For purposes of clarity and by way of example, in the event that (a) Ayers becomes entitled to receive the Separation Package pursuant
to Section 7.5 on August 31, 2006 and (b) CryoCor determines to delay the first six months of payments of the Separation Package until six months after August 31, 2006 pursuant to the second preceding sentence, at the end of such
six-month period Ayers shall receive, at the time of CryoCor’s next payment to its employees under its regular payroll cycle, payments in an amount equal to the first six months of payments of the Separation Package plus any other portion of
the Separation Package due at such time, and thereafter shall receive the remainder of the Separation Package in equal installments over the remainder of the applicable twelve-month period, subject, in each case, to standard deductions and
withholdings. Ayers agrees that the severance payments may be reduced by CryoCor to fulfill any outstanding payments or debts due and owing by Ayers to CryoCor following written notice of its intent to make such deductions.” 
 8. Section 7.5 of the Agreement is amended and restated to add the following sentences to its end: “If this Agreement expires without having been extended by
mutual written agreement of Ayers and CryoCor pursuant to Section 3 and Ayers’ employment with CryoCor is thereby terminated, Ayers will be entitled to receive the Separation Package described in subsection 7.2(a) above, provided that
Ayers complies with all of the conditions in subsection 7.2(b) above. All other CryoCor obligations to Ayers pursuant to this Agreement will become automatically terminated and completely extinguished as of such termination of employment.”

 9. Section 7.6(a) of the Agreement is amended and restated as follows: “(a) Change of Control Separation Package. If Ayers’
employment is terminated by CryoCor or its successor within twelve (12) months after a Change in Control (as that term is defined below), other than for Cause (as defined in subsection 7.1 above), or Ayers resigns for Good Reason (as
defined in subsection 7.3 above), Ayers shall be entitled to receive the following “Change of Control Separation Package,” provided that Ayers complies with all the conditions described in subsection 7.2(b) above: a severance payment
equal to $450,000, subject to standard deductions and withholdings and payable in equal installments over twelve months in accordance with CryoCor’s regular payroll cycle; and (ii) all unvested shares under the Options shall automatically
vest and/or thereafter be subject to no repurchase rights of CryoCor. Ayers agrees that the severance payments may be reduced by CryoCor to fulfill any outstanding payments or debts due and owing by Ayers to CryoCor following written notice of its
intent to make such deductions.” 
 10. Section 7.7 of the Agreement, and references thereto in the Agreement, are hereby deleted in their
entirety. 
 11. By signing this letter amendment you agree and understand that in the event your employment is terminated, whether by expiration of this
Agreement or otherwise, and notwithstanding anything to the contrary in CryoCor’s 2000 Stock Option Plan (the “Plan”) or CryoCor’s 2005 Equity Incentive Plan (the “2005 Plan”) or any option (including the Options)
granted thereunder, the vesting of any option (including the Options) you hold to purchase CryoCor stock shall continue only for up to one year from the date of termination of your employment with CryoCor and only for so long during such one-year
period as you continue to serve on CryoCor’s Board of Directors. You agree and understand that (a) in the event your 

 
employment with CryoCor is terminated, whether by expiration of this Agreement or otherwise, any subsequent service to CryoCor as a director shall only
constitute (i) “Continuous Service” for purposes of and within the meaning of the 2005 Plan or any options (including the Options) you hold under the 2005 Plan for up to one year from the date of termination of your employment with
CryoCor, and only for so long during such one-year period as you continue to serve CryoCor as a director, or (ii) ”Service” for purposes of and within the meaning of the Plan or any options (including the Options) you hold under the
Plan for up to one year from the date of termination of your employment with CryoCor, and only for so long during such one-year period as you continue to serve CryoCor as a director, and (b) your “Continuous Service” and
“Service,” as applicable, shall be deemed to have been terminated upon the termination of your employment with CryoCor if you no longer serve on CryoCor’s Board of Directors at the time of such termination or, if you do continue to
serve on CryoCor’s Board of Directors at the time of termination of your employment with CryoCor, upon the earlier of (i) one year from the date of termination of your employment with CryoCor or (ii) the date during such one-year
period upon which you cease to be a member of CryoCor’s Board of Directors. You agree and understand that all of your options to purchase CryoCor stock (including the Options) shall be deemed amended to provide for the foregoing. In addition,
all references in the Agreement to “provided further that Ayers shall have rights with respect to the Options as provided in the respective option agreements related thereto” and similar language shall be amended and restated to
“provided further that Ayers shall have rights with respect to the Options as provided in the respective option agreements related thereto, as modified pursuant to the terms of this Agreement.” Notwithstanding the foregoing, this paragraph
shall not apply to any option granted to you, if any, as a non-employee director of CryoCor pursuant to CryoCor’s 2005 Non-Employee Directors’ Stock Option Plan. 
 12. By signing this letter amendment, you agree and consent that no change effected by this letter amendment shall constitute Good Reason under the Agreement. 

 Please signify your agreement to the foregoing amendment by signing as indicated below and returning your signature to me
by no later than the close of business March 22, 2006. 
  

	
	 Sincerely,
  
 CRYOCOR, INC.

	
	 /s/ Kurt C. Wheeler

	 Kurt C. Wheeler

	 Chairman

 In witness hereof, the parties have executed this amendment on the day and year indicated below.

 I have read and agree and consent to the foregoing amendment. 
  

					
		 		 	 GREGORY M. AYERS

			
	 Dated: 3/21/06
	 		 	 /s/ Gregory M. Ayers

  

									
		 		 	 CRYOCOR, INC.

				
	 Dated: 3/21/06
	 		 	 By:
	 	 /s/ Kurt C. Wheeler

		 		 		 		 	Kurt C. Wheeler
		 		 		 		 	ChairmanForm of Restricted Stock Award

 Exhibit 10.2 
 March 15, 2006 
 [Name] 
 [Title] 
  

	Re:	WESTLAKE CHEMICAL CORPORATION 

 RESTRICTED STOCK
AWARD 
 Dear : 
 Westlake
Chemical Corporation (the “Company”) is pleased to notify you that you have been granted an award (“Award”) of              shares of Common Stock of the Company
(“Restricted Stock”). This Award is granted effective March 15, 2006 (the “Grant Date”), subject to the following terms and conditions: 
 1. Relationship to Plan. This Award is subject to all of the terms, conditions and provisions of the Westlake Chemical Corporation 2004 Omnibus Incentive Plan (the “Plan”) and administrative
interpretations thereunder, if any, which have been adopted by the Administrator and are in effect on the date hereof. Except as defined herein, capitalized terms shall have the same meanings ascribed to them under the Plan. 
 2. Vesting Schedule. 
 (a) This Award
shall vest in accordance with the following schedule: 
  

			
	 Period Beginning
	  	 Per Cent of Shares Vested

	 March 15, 2007
	  	33 1/3%
	 March 15, 2008
	  	33 1/3%
	 March 15, 2009
	  	33 1/3%

 You must be in continuous regular, full-time employment with the Company or any of its
Subsidiaries from the Grant Date through the date this Award is scheduled to vest in order for the Award to vest. During the period of time between the Grant Date and the earlier of the date the Restricted Stock vests or is forfeited, the Restricted
Stock will be evidenced by a book entry account in the Company’s records. Fractional shares will be rounded for purposes of vesting in accordance with Plan policy. 
 (b) All Restricted Stock subject to this Award shall vest, irrespective of the limitations set forth in subparagraph(a) above, in the event of your termination of employment with the Company or any of its
Subsidiaries due to death. 
 3. Forfeiture of Award. If your employment terminates other than by reason of death, all unvested
Restricted Stock as of the termination date shall be forfeited. 
 4. Distribution Following Termination of Restrictions. Subject to
the other provisions of this Award and the Plan, the Restricted Stock shall vest as set forth in Paragraph 2 and shall be distributed to you (or your beneficiary) as soon as practicable after the Restricted Stock vests. Distribution of Common Stock
will be subject to withholding taxes as described in Paragraph 

 5, and may be in a form selected by the Company, in its discretion, including deposit into a custodial
account or delivery of a stock certificate. 
 5. Withholding. At the time of issuance of Common Stock upon the vesting of the
Restricted Stock, the Company shall withhold an appropriate number of shares of Common Stock, having a Fair Market Value determined in accordance with the Plan, equal to the amount necessary to satisfy the minimum federal, state and local tax
withholding obligation with respect to this Award. The distribution of Common Stock described in Paragraph 4 will be net of such shares of Common Stock that are withheld to satisfy applicable taxes pursuant to this Paragraph. In lieu of withholding
of shares of Common Stock, the Administrator may, in its discretion, authorize tax withholding to be satisfied by a cash payment to the Company, by withholding an appropriate amount of cash from base pay, or by such other method as the Administrator
determines may be appropriate to satisfy all obligations for withholding of such taxes. No election under section 83(b) of the Internal Revenue Code shall be permitted with respect to this Award. 
 6. Assignment of Award. Your rights under the Plan and this Restricted Stock Award are personal; no assignment or transfer of your rights under and
interest in this Award may be made by you other than by will or by the laws of descent and distribution. 
 7. Dividends and Voting
Rights. You are entitled to receive all dividends and other distributions made with respect to Restricted Stock registered or held in book entry in your name and you are entitled to vote or execute proxies with respect to such Restricted Stock,
unless and until the Restricted Stock is forfeited. 
 8. No Employment Guaranteed. No provision of this Restricted Stock Award shall
give you any right to continued employment with the Company or any Subsidiary. 
 9. Requirements of Law and Stock Exchanges. Your
rights to the Restricted Stock and the issuance and delivery of the Common Stock are subject to compliance with all applicable requirements of law. In addition, the Company shall not be obligated to deliver any shares of Common Stock if counsel to
the Company determines that such delivery would violate any applicable law or any rule or regulations of any governmental authority or any rule or regulation of, or agreement of the Company with, any securities exchange or association upon which the
Common Stock is listed or quoted. 
 10. Governing Law. This Restricted Stock Award shall be governed by, construed, and enforced in
accordance with the laws of the State of Texas. 
 In conjunction with this award we are required to provide you with the latest relevant SEC filings by the
Company; therefore, we refer you to the SEC Filings section of our web page, www.westlakechemical.com . If you have any questions regarding this award, you may contact Mr. David Hansen, Sr. Vice President, Administration, at
713-960-9111. 
  

	
	Yours very truly,
	
	 /s/ Albert Chao

	Albert Chao
	President and Chief Executive Officer

  

 -2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]